In NSCLC cells, apigenin was effective regardless of EGFR genotype, reducing CD26 expression and disrupting downstream signaling involving p-Akt and Snail/Slug, thereby impairing EMT-driven invasiveness [40]. Here, AKT1 is linked to non-small cell lung carcinoma.